Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma
Authors
Keywords
Ovarian cancer, MAPK signaling cascades, Phosphorylation, Estrogens, Cancer treatment, Cell cycle and cell division, Hyperexpression techniques, Gene expression
Journal
PLoS One
Volume 8, Issue 2, Pages e54103
Publisher
Public Library of Science (PLoS)
Online
2013-02-05
DOI
10.1371/journal.pone.0054103
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serine-305 Phosphorylation Modulates Estrogen Receptor Alpha Binding to a Coregulator Peptide Array, with Potential Application in Predicting Responses to Tamoxifen
- (2012) R. Houtman et al. MOLECULAR CANCER THERAPEUTICS
- Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice
- (2011) E Buache et al. ONCOGENE
- Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study
- (2010) Allan L. Covens et al. GYNECOLOGIC ONCOLOGY
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Molecular Characterization of 103 Ovarian Serous and Mucinous Tumors
- (2010) Ildikó Vereczkey et al. PATHOLOGY & ONCOLOGY RESEARCH
- Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics
- (2010) Amy L. Gross et al. Journal of Oncology
- Defining the Cut Point Between Low-grade and High-grade Ovarian Serous Carcinomas
- (2009) Ayse Ayhan et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor α serine 167 phosphorylation
- (2009) Rachel L. Yamnik et al. FEBS LETTERS
- Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors
- (2009) Hugo Arias-Pulido et al. GYNECOLOGIC ONCOLOGY
- A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer
- (2009) Peter A. Argenta et al. GYNECOLOGIC ONCOLOGY
- Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells
- (2009) Robert X.-D. Song et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells
- (2009) Y.-K. Yoon et al. MOLECULAR CANCER THERAPEUTICS
- Investigating Differential Dynamics of the MAPK Signaling Cascade Using a Multi-Parametric Global Sensitivity Analysis
- (2009) Jeongah Yoon et al. PLoS One
- Amplification and invasiveness of epithelial progenitors during gastric carcinogenesis in trefoil factor 1 knockout mice
- (2008) S. M. Karam et al. CELL PROLIFERATION
- Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
- (2008) Kathleen M. Schmeler et al. GYNECOLOGIC ONCOLOGY
- Systematic Mapping of Posttranslational Modifications in Human Estrogen Receptor-α with Emphasis on Novel Phosphorylation Sites
- (2008) Christian Atsriku et al. MOLECULAR & CELLULAR PROTEOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started